These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

568 related items for PubMed ID: 28064110

  • 1. Clinical use of Hypericum perforatum (St John's wort) in depression: A meta-analysis.
    Ng QX, Venkatanarayanan N, Ho CY.
    J Affect Disord; 2017 Mar 01; 210():211-221. PubMed ID: 28064110
    [Abstract] [Full Text] [Related]

  • 2. St. John's wort.
    Lawvere S, Mahoney MC.
    Am Fam Physician; 2005 Dec 01; 72(11):2249-54. PubMed ID: 16342849
    [Abstract] [Full Text] [Related]

  • 3. A systematic review and meta-analysis of Hypericum perforatum in depression: a comprehensive clinical review.
    Whiskey E, Werneke U, Taylor D.
    Int Clin Psychopharmacol; 2001 Sep 01; 16(5):239-52. PubMed ID: 11552767
    [Abstract] [Full Text] [Related]

  • 4. Mechanism of action of St John's wort in depression : what is known?
    Butterweck V.
    CNS Drugs; 2003 Sep 01; 17(8):539-62. PubMed ID: 12775192
    [Abstract] [Full Text] [Related]

  • 5. Current St John's wort research from mode of action to clinical efficacy.
    Müller WE.
    Pharmacol Res; 2003 Feb 01; 47(2):101-9. PubMed ID: 12543057
    [Abstract] [Full Text] [Related]

  • 6. St. John's wort (Hypericum perforatum) and depression: what happens to the neurotransmitter systems?
    Kholghi G, Arjmandi-Rad S, Zarrindast MR, Vaseghi S.
    Naunyn Schmiedebergs Arch Pharmacol; 2022 Jun 01; 395(6):629-642. PubMed ID: 35294606
    [Abstract] [Full Text] [Related]

  • 7. [Hypericin and hyperforin: bioactive components of St. John's Wort (Hypericum perforatum). Their isolation, analysis and study of physiological effect].
    Vacek J, Klejdus B, Kubán V.
    Ceska Slov Farm; 2007 Apr 01; 56(2):62-6. PubMed ID: 17619301
    [Abstract] [Full Text] [Related]

  • 8. Use of serotonergic antidepressants and St John's wort in older Australians: a population-based cohort study.
    Rahman SZ, Basilakis J, Rahmadi A, Lujic S, Musgrave I, Jorm L, Hay P, Münch G.
    Australas Psychiatry; 2013 Jun 01; 21(3):262-6. PubMed ID: 23439542
    [Abstract] [Full Text] [Related]

  • 9. St. John's wort: a new alternative for depression?
    Josey ES, Tackett RL.
    Int J Clin Pharmacol Ther; 1999 Mar 01; 37(3):111-9. PubMed ID: 10190758
    [Abstract] [Full Text] [Related]

  • 10. St John's wort: Prozac from the plant kingdom.
    Di Carlo G, Borrelli F, Ernst E, Izzo AA.
    Trends Pharmacol Sci; 2001 Jun 01; 22(6):292-7. PubMed ID: 11395157
    [Abstract] [Full Text] [Related]

  • 11. St. John's wort: role of active compounds for its mechanism of action and efficacy.
    Butterweck V, Schmidt M.
    Wien Med Wochenschr; 2007 Jun 01; 157(13-14):356-61. PubMed ID: 17704987
    [Abstract] [Full Text] [Related]

  • 12. St John's wort (Hypericum perforatum L.): a review of its chemistry, pharmacology and clinical properties.
    Barnes J, Anderson LA, Phillipson JD.
    J Pharm Pharmacol; 2001 May 01; 53(5):583-600. PubMed ID: 11370698
    [Abstract] [Full Text] [Related]

  • 13. About the cover: St. John's wort.
    J Soc Integr Oncol; 2006 May 01; 4(1):52-5. PubMed ID: 16737673
    [Abstract] [Full Text] [Related]

  • 14. Kava and St. John's Wort: current evidence for use in mood and anxiety disorders.
    Sarris J, Kavanagh DJ.
    J Altern Complement Med; 2009 Aug 01; 15(8):827-36. PubMed ID: 19614563
    [Abstract] [Full Text] [Related]

  • 15. [St. John's wort (Hypericum perforatum L.). A plant with relevance for dermatology].
    Schempp CM, Müller KA, Winghofer B, Schöpf E, Simon JC.
    Hautarzt; 2002 May 01; 53(5):316-21. PubMed ID: 12063742
    [Abstract] [Full Text] [Related]

  • 16. Understanding drug interactions with St John's wort (Hypericum perforatum L.): impact of hyperforin content.
    Chrubasik-Hausmann S, Vlachojannis J, McLachlan AJ.
    J Pharm Pharmacol; 2019 Jan 01; 71(1):129-138. PubMed ID: 29411879
    [Abstract] [Full Text] [Related]

  • 17. St. John's wort in mild to moderate depression: the relevance of hyperforin for the clinical efficacy.
    Laakmann G, Schüle C, Baghai T, Kieser M.
    Pharmacopsychiatry; 1998 Jun 01; 31 Suppl 1():54-9. PubMed ID: 9684948
    [Abstract] [Full Text] [Related]

  • 18. [Meta-analysis of effectiveness and tolerability of treatment of mild to moderate depression with St. John's Wort].
    Röder C, Schaefer M, Leucht S.
    Fortschr Neurol Psychiatr; 2004 Jun 01; 72(6):330-43. PubMed ID: 15211398
    [Abstract] [Full Text] [Related]

  • 19. St John's wort (Hypericum perforatum) in major depression.
    Shelton RC.
    J Clin Psychiatry; 2009 Jun 01; 70 Suppl 5():23-7. PubMed ID: 19909690
    [Abstract] [Full Text] [Related]

  • 20. Functional induction and de-induction of P-glycoprotein by St. John's wort and its ingredients in a human colon adenocarcinoma cell line.
    Tian R, Koyabu N, Morimoto S, Shoyama Y, Ohtani H, Sawada Y.
    Drug Metab Dispos; 2005 Apr 01; 33(4):547-54. PubMed ID: 15640377
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.